InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Henson Heidi. Insider active across 3 companies, notably LISATA THERAPEUTICS, INC.. Cumulatively, 6 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €95k. Activity tracked since 9 January 2023. The latest transaction was filed on 9 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
HENSON HEIDI is a declarant linked to LISATA THERAPEUTICS, INC., Perspective Therapeutics, Inc. and Pardes Biosciences, INC., with the role of Director at the first two and Chief Financial Officer at Pardes Biosciences, INC. The record shows 6 filings in total, and across the sampled recent filings from 2023-01-11 to 2026-01-13, buys amount to EUR 95144 and sells to EUR 0, with Attribution as the modal transaction nature.